Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : LIFE save search
aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis
Published: 2021-09-13 (Crawled : 12:00) - globenewswire.com
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 14.96%
H: 47.46%
C: 45.24%
phase 1 positive trial phase 1b phase 2b response
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Announce Positive Data from a Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response of ATYR1923 in Pulmonary Sarcoidosis
Published: 2021-09-13 (Crawled : 12:00) - globenewswire.com
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 14.96%
H: 47.46%
C: 45.24%
biopharma phase 1 positive trial phase 1b phase 2b
aTyr Pharma Announces Fourth Quarter and Full Year 2020 Results and Provides Corporate Update
Published: 2021-03-23 (Crawled : 21:00) - globenewswire.com
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 11.38%
H: 0.9%
C: -14.96%
results pharma
aTyr Pharma Announces New tRNA Synthetase Discovery Programs
Published: 2021-02-11 (Crawled : 13:03) - globenewswire.com
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 9.66%
H: 0.44%
C: -7.93%
program pharma
aTyr Pharma Announces Pricing of $75 Million Public Offering of Common Stock
Published: 2021-09-16 (Crawled : 13:00) - biospace.com/
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 8.72%
H: 23.72%
C: 10.76%
offering pharma
aTyr Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2021-03-11 (Crawled : 14:32) - biospace.com/
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 6.7%
H: 3.9%
C: 3.68%
cancer research pharma
aTyr Pharma to Present at November Investor Conferences
Published: 2023-11-01 (Crawled : 12:00) - globenewswire.com
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 5.6%
H: 0.0%
C: -6.82%
pharma
aTyr Pharma to Present Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference
Published: 2022-04-01 (Crawled : 20:00) - biospace.com/
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 4.67%
H: 6.61%
C: -0.18%
atyr1923 pharma conference international
aTyr Pharma Announces Positive Biomarker Data from Phase 2 Clinical Trial of ATYR1923 Demonstrating Anti-Inflammatory Effects in COVID-19 Patients with Severe Respiratory Complications
Published: 2021-03-15 (Crawled : 15:00) - biospace.com/
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 4.41%
H: 1.42%
C: -5.39%
covid phase 2 positive respiratory trial biomarkers
aTyr Pharma and Foundation for Sarcoidosis Research Announce Town Hall Virtual Meeting on Sarcoidosis and Transitioning from Steroids to New and Investigational Therapies
Published: 2023-03-20 (Crawled : 14:00) - biospace.com/
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 4.26%
H: 1.62%
C: -2.04%
pharma research meeting
aTyr Pharma Announces Positive End-of-Phase 2 Meeting with FDA on Efzofitimod for the Treatment of Pulmonary Sarcoidosis
Published: 2022-03-10 (Crawled : 14:00) - globenewswire.com
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 3.62%
H: 6.6%
C: 2.33%
treatment fda phase 2 pos positive
BioSpace Movers & Shakers, Dec. 31
Published: 2021-12-31 (Crawled : 06:00) - biospace.com/
PSTX | $2.15 -0.23% -0.23% 420K
|
Health Technology
|
| O: -0.28%
H: 1.17%
C: -2.99%
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 0.0%
H: 3.6%
C: -0.4%
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: 2.97%
H: 0.4%
C: -6.13%
space spac
aTyr Pharma Announces Dosing of First Patient in Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis
Published: 2022-09-27 (Crawled : 13:00) - biospace.com/
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 2.83%
H: 0.0%
C: -4.12%
pharma study
aTyr Pharma Announces Achievement of Development Milestone by Partner Kyorin Pharmaceutical, Co., Ltd.
Published: 2023-02-06 (Crawled : 15:00) - biospace.com/
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 2.61%
H: 6.36%
C: 3.81%
pharma milestone
aTyr Pharma to Present Poster Highlighting Research Approach for Identifying Receptor Targets for Extracellular tRNA Synthetases
Published: 2021-01-22 (Crawled : 13:01) - globenewswire.com
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 2.55%
H: 7.96%
C: 0.25%
research pharma
Financial Reporting Analyst
Published: 2022-07-18 (Crawled : 22:00) - atyrpharma.com
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 2.33%
H: 0.0%
C: -2.28%
Senior Accountant
Published: 2022-07-18 (Crawled : 22:00) - atyrpharma.com
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 2.33%
H: 0.0%
C: -2.28%
aTyr Pharma Presents Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference
Published: 2022-05-17 (Crawled : 13:20) - biospace.com/
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 2.27%
H: 3.81%
C: 1.59%
atyr1923 pharma conference international
aTyr Pharma Announces Co-Founder of the Foundation for Sarcoidosis Research and Leading Sarcoidosis Advocate Andrea Wilson as Patient Advisor
Published: 2021-04-08 (Crawled : 16:00) - biospace.com/
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 2.16%
H: 5.18%
C: 1.65%
research pharma
Scientist/Sr. Scientist, Immunology
Published: 2022-02-07 (Crawled : 22:00) - atyrpharma.com
LIFE | $1.62 -1.22% -1.23% 220K
|
Health Technology
|
| O: 2.16%
H: 0.18%
C: -1.23%
immunology
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.